首页> 外文期刊>Toxicologic pathology >Macrophage Populations and Expression of Regulatory Inflammatory Factors in Hepatic Macrophage-depleted Rat Livers under Lipopolysaccharide (LPS) Treatment
【24h】

Macrophage Populations and Expression of Regulatory Inflammatory Factors in Hepatic Macrophage-depleted Rat Livers under Lipopolysaccharide (LPS) Treatment

机译:巨噬细胞(LPS)治疗下肝巨噬细胞耗尽大鼠肝脏调节炎症因子的巨噬细胞群体和表达

获取原文
获取原文并翻译 | 示例
           

摘要

To investigate the significance of the appearance of hepatic macrophages and expression of inflammatory factors in normal and macrophage-depleted livers, hepatic macrophages were depleted with liposome (Lipo)-encapsulated clodronate (CLD; 50 mg/kg, i.v.) followed by lipopolysaccharide (LPS) administration (0.1 mg/kg, i.p.) in F344 rats (CLD + LPS). Vehicle control rats (Lipo + LPS) received empty-Lipo before LPS. The low dose of LPS did not result in microscopic changes in the liver in either treatment group but did modulate M1 and M2 macrophage activity in Lipo + LPS rats without altering repopulating hepatic macrophages in CLD + LPS rats. LPS treatment in Lipo + LPS rats dramatically increased the M1 (IL-1 beta, IL-6, TNF-alpha, and MCP-1) but not M2 macrophage-related factors (IL-4 and CSF-1) compared to CLD + LPS rats. In the CLD LPS rats, the M2 macrophage-related factors IL-4 and CSF-1 were elevated. In conclusion, low-dose LPS activated hepatic macrophages in rat livers without causing liver injury or stimulating repopulating hepatic macrophages. These data suggest that LPS may alter the liver microenvironment by modulating M1 or M2 macrophage-related inflammatory mediators and macrophage-based hepatotoxicity.
机译:为了探讨肝巨噬细胞外观和正常和巨噬细胞耗尽肝脏的炎症因子表达的重要性,用脂质体(Lipo) - 持续的克莱膦酸克(Cld; 50mg / kg,iv)耗尽肝巨噬细胞,然后用脂多糖(LPS )在F344大鼠(CLD + LPS)中给药(0.1mg / kg,IP)。车辆对照大鼠(Lipo + LPS)在LPS之前接受空脂。低剂量的LP不会导致任一治疗组中肝脏的显微变化,但在Lipo + LPS大鼠中调节M1和M2巨噬细胞活性,而不改变CLD + LPS大鼠中的重新灌注肝巨噬细胞。 LIPO + LPS大鼠的LPS处理显着增加了M1(IL-1β,IL-6,TNF-α和MCP-1),但与CLD +相比,不是M2巨噬细胞相关因子(IL-4和CSF-1) LPS大鼠。在CLD LPS大鼠中,M2巨噬细胞相关因子IL-4和CSF-1升高。总之,低剂量LPS​​在大鼠肝脏中激活肝巨噬细胞,而不会引起肝损伤或刺激重新灌注肝巨噬细胞。这些数据表明,LPS可以通过调节M1或M2巨噬细胞相关的炎症介质和基于巨噬细胞的肝毒性来改变肝脏微环境。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号